Helen Susan Kim, EVP, Business Development at Kite Pharma, Inc. (KITE), sold 42,700 shares at $65.81 ($2.9M) on 2017-02-28, disclosed to the SEC on 2017-03-02.
Open-market sale of $2.9M KITE by EVP, Business Development. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $65.81 | 18,072 | $1.2M | 41.2% |
| 2 | $66.32 | 10,326 | $685K | 23.7% |
| 3 | $68.74 | 900 | $62K | 2.1% |
| 4 | $69.63 | 2,553 | $178K | 6.2% |
| 5 | $71.16 | 9,049 | $644K | 22.3% |
| 6 | $71.65 | 1,800 |
| $129K |
| 4.5% |
| Total | $67.60 avg | 42,700 | $2.9M | 100% |
| Filing → |
| AMTI | SELL | 2021-08-25 | $585K | — | Filing → |
| AMTI | SELL | 2021-07-06 | $17.3M | — | Filing → |
| KITE | SELL | 2017-09-27 | $1.1M | — | Filing → |